Veterinary Drug terms — page 21 | HESTIA Glossary

Browse all 1,061 veterinary drug terms HESTIA uses to describe agricultural data — with definitions and synonyms. Free and open.

Trimethoprim 5-((3,4,5-trimethoxyphenyl)methyl)-2,4-pyrimidinediamine; trimethoprim; 738-70-5; Proloprim; Trimpex; Trimetoprim; Bactramin; Monotrim; Monotrimin; Trimopan; 2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine; Monoprim; Syraprim; Trimanyl; Wellcoprim; Triprim; Uretrim; 5-(3,4,5-trimethoxybenzyl)pyrimidine-2,4-diamine; Trimethoprime; Trimethoprimum; Abaprim; Apo-Sulfatrim; Antrimox; Bacticel; Bactoprim; Bethaprim; Biosulten; Briscotrim; Chemotrin; Colizole; Cotrimel; Espectrin; Fermagex; Kombinax; Lagatrim; Metoprim; NIH 204; Novotrimel; Pancidim; Salvatrim; Sinotrim; Streptoplus; Sugaprim; Sulfamar; Sulfoxaprim; Sulthrim; Trimexol; Trimezol; Trisulcom; Trisulfam; Trisural; Wellcoprin; Xeroprim; Zamboprim; Anitrim; Antrima; Bacdan; Bacidal; Bacide; Bencole; Conprim; Deprim; Duocide; Esbesul; Euctrim; Exbesul; Fortrim; Ikaprim; Lastrim; Omstat; Protrin; Purbal; Resprim; Roubac; Roubal; Setprin; Stopan; Sultrex; Toprim; Trimono; Trisul; Utetrin; Velaten; Bacin; Bacta; Cidal; Futin; Trimpex 200; Co-Trimoxizole; Lagatrim Forte; Septrin Forte; Alcorim-F; Colizole DS; Septrin S; Septrin DS; Smz-Tmp; NSC-106568; Trimez-IFSA; U-Prin; component of Septra; 5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine; Bactifor; Dosulfin; Trimetoprim [DCIT]; Lescot; Trimetoprim [Polish]; Resprim Forte; Uro-D S; BW 56-72; Tmp Smx; 2,4-Pyrimidinediamine, 5-[(3,4,5-trimethoxyphenyl)methyl]-; Primsol; Trimethoprime [INN-French]; Trimethoprimum [INN-Latin]; Trimetoprima [INN-Spanish]; Polytrim; NIH 204 (VAN); TCMDC-125538; UNII-AN164J8Y0X; 5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine; NSC 106568; WR 5949; CCRIS 2410; 5-(3,4,5-Trimethoxybenzyl)-2,4-diaminopyrimidine; CHEBI:45924; HSDB 6781; CHEMBL22; EINECS 212-006-2; Trimpex (TN); BW 5672; 5-(3,4,5-Trimethoxybenzyl)-2,4-pyrimidinediamine; BRN 0625127; Pyrimidine, 2,4-diamino-5-(3,4,5-trimethoxybenzyl)-; AI3-52594; MLS000079023; AN164J8Y0X; Trimethioprim; 2,4-Pyrimidinediamine, 5-((3,4,5-trimethoxyphenyl)-methyl)-; 2,4-Pyrimidinediamine, 5-((3,4,5-trimethoxyphenyl)methyl)-; IEDVJHCEMCRBQM-UHFFFAOYSA-N; NSC106568; Trimethoprim, 98%; NCGC00016055-05; Trimethopriom; 5-((3,4,5-Trimethoxyphenyl)methyl)-2,4-pyrimidinediamine; AK154007; CAS-738-70-5; Instalac; SMR000035999; Trimogal; Tiempe; DSSTox_CID_3712; DSSTox_RID_77158; DSSTox_GSID_23712; W-104441; 2,4-Diamino-5-(3',4',5'-trimethoxybenzyl)pyrimidine; Bacterial [Antibiotic]; Bacterial; Proloprim (TN); SR-01000075652; Trimethoprim [USAN:BAN:INN:JAN]; 5-(3, 4, 5-Trimethoxybenzyl)-2, 4-pyrimidinediamine; Trimethoprim (JAN/USP/INN); 5-{[3,4,5-tris(methyloxy)phenyl]methyl}pyrimidine-2,4-diamine; B-Lock; KUC103659N; Trimethoprim,(S); Prestwick_485; KSC-4-158; Trimethoprim (TMP); AZT + TMP/SMX (mixture) combination; Spectrum_000167; Tocris-0650; Trimethoprim [USAN:USP:INN:BAN:JAN]; 2w9h; 3fl9; 3n0h; 3s3v; 4km2; BW-56-72; 56585-33-2; Opera_ID_1760; Prestwick0_000208; Prestwick1_000208; Prestwick2_000208; Prestwick3_000208; Spectrum2_000937; Spectrum3_000643; Spectrum4_000372; Spectrum5_001559; Lopac-T-7883; Epitope ID:119684; UPCMLD-DP132; T 7883; Lopac0_001271; Oprea1_495058; SCHEMBL24506; BSPBio_000195; BSPBio_002245; KBioGR_000863; KBioSS_000647; 5-25-13-00429 (Beilstein Handbook Reference); KSC492O7H; MLS001201740; MLS002303068; MLS002548881; ARONIS24118; BIDD:GT0190; DivK1c_000589; SPECTRUM1500595; SPBio_000874; SPBio_002116; BPBio1_000215; DTXSID3023712; UPCMLD-DP132:001; BDBM18069; CTK3J2773; HMS501N11; KBio1_000589; KBio2_000647; KBio2_003215; KBio2_005783; KBio3_001465; BBC/254; BIT0154; NIH-204; Trimethoprim, >=98% (HPLC); NINDS_000589; ZX-AFC000683; 2,4,5-trimethoxybenzyl)pyrimidine; HMS1568J17; HMS1921I03; HMS2090D14; HMS2092A10; HMS2095J17; HMS2230L06; HMS3259I11; HMS3263P04; HMS3371O18; HMS3652E03; HMS3712J17; Pharmakon1600-01500595; 2,4,5-trimethoxyphenzyl)pyrimidine; ALBB-028968; BCP12148; HY-B0510; KS-00000KQ6; KS-000046JM; ZINC6627681; ZX-AN079781; ZX-AS004468; Tox21_110291; Tox21_200157; Tox21_501271; ANW-42623; BBL005584; BG0348; CCG-40335; GA3656; KM1575; MFCD00036761; NSC752719; NSC757370; s3129; SBB080617; STK177322; STL455117; AKOS001650069; Tox21_110291_1; AC-8427; API0004694; BW-5672; CS-2718; DB00440; KS-1145; LP01271; LS-1627; MCULE-6670904388; NC00483; NSC-752719; NSC-757370; RTR-023930; SDCCGSBI-0051237.P004; IDI1_000589; SMP2_000262; Trimethoprim 100 microg/mL in Methanol; NCGC00016055-01; NCGC00016055-02; NCGC00016055-03; NCGC00016055-04; NCGC00016055-06; NCGC00016055-07; NCGC00016055-08; NCGC00016055-09; NCGC00016055-10; NCGC00016055-11; NCGC00016055-12; NCGC00016055-13; NCGC00016055-14; NCGC00016055-16; NCGC00016055-17; NCGC00024707-01; NCGC00024707-03; NCGC00024707-04; NCGC00024707-05; NCGC00024707-06; NCGC00024707-07; NCGC00024707-08; NCGC00257711-01; NCGC00261956-01; CC-35383; CPD000035999; H148; SAM002264649; SC-15159; ST024737; Trimethoprim/sulfamethoxazole (commercial); SBI-0051237.P003; AB0007348; AB1004879; DB-055812; TR-023930; Trimethoprim 100 microg/mL in Acetonitrile; 2, 5-[(3,4,5-trimethoxyphenyl)methyl]-; AB00052118; BB 0258034; EU-0101271; FT-0601630; ST24044174; SW196690-3; C01965; D00145; J10046; Trimethoprim, crystallized, >=99.0% (HPLC); WLN: T6N CNJ BZ DZ E1R CO1 DO1 EO1; 5-(3,5-Trimethoxybenzyl)-2,4-diaminopyrimidine; AB00052118-30; AB00052118-32; AB00052118_33; AB00052118_34; Trimethoprim, VETRANAL(TM), analytical standard; 738T705; C-18214; Formulated trimethoprim (NSC 106568) in ethanol; Q422665; 2,4-diamino-5-(3,4,5-trimethoxybenzyl) pyrimidine; 2,4-diamino-5-(3,4,5-trimethoxybenzyl)-pyrimidine; Pyrimidine,4-diamino-5-(3,4,5-trimethoxybenzyl)-; SR-01000075652-1; SR-01000075652-3; SR-01000075652-6; 5-(3,4,5-Trimethoxy-benzyl)-pyrimidine-2,4-diamine; 5-(3,4,5-Trimethoxybenzyl)-2,4-pyrimidinediamine #; BRD-K07208025-001-06-5; SR-01000075652-10; 2-amino-5-(3,4,5-trimethoxybenzyl)-4-pyrimidinylamine; F0914-5266; Trimethoprim, certified reference material, TraceCERT(R); Z1522566629; 5-(3,4,5-trimethoxybenzyl)pyrimidine-2,4(1H,3H)-diimine; Trimethoprim, British Pharmacopoeia (BP) Reference Standard; 2,4-DIAMINO-5-(3',4',5'-TRIMETHOXYBENZYL)PYRIMIDIN; Trimethoprim, European Pharmacopoeia (EP) Reference Standard; Trimethoprim, United States Pharmacopeia (USP) Reference Standard; TRIMETHOPRIM (8064-90-2 (TRIMETHOPRIM/SULFAMETHOXAZOLE); TMP/SMX (MIXTURE)); Trimethoprim for system suitability, European Pharmacopoeia (EP) Reference Standard; Trimethoprim, Pharmaceutical Secondary Standard; Certified Reference Material; Trimethoprim; 5-25-13-00429 (Beilstein Handbook Reference)
Triphosphopyridine nucleotide 2'-(Dihydrogen phosphate)adenosine 5'-(trihydrogen diphosphate)P'-5'-ester with 3-(aminocarbonyl)-1-beta-D-ribofuranosylpyridinium, inner salt; NADP; 4-26-00-03672 (Beilstein Handbook Reference)
Triptorelin 6-D-Tryptophan-luteinizing hormone-releasing factor (swine); Triptorelin; Triptorelin
Trypan blue 3,3'-[(3,3'-Dimethyl[1,1'-biphenyl]-4,4'-diyl)bis(aso)]bis-5-amino-4-hydroxy-2,7-naphthalenedisulfonic acid, Tetrasodium salt; Trypan Blue; C.I. 23850
Tryptamine 1H-Indole-3-ethanamine; tryptamine; 61-54-1; 3-(2-aminoethyl)indole; 2-(1H-Indol-3-yl)ethanamine; 1H-Indole-3-ethanamine; 2-(3-Indolyl)ethylamine; Indol-3-ethylamine; Tryptamin; 2-(Indol-3-yl)ethylamine; Indole, 3-(2-aminoethyl)-; 2-(1H-Indol-3-Yl)Ethan-1-Amine; 3-Indoleethylamine; 2-(1H-indol-3-yl)ethylamine; 2-Indol-3-ylethylamine; UNII-422ZU9N5TV; (Amino-2 ethyl)-3 indole; MFCD00005661; (Amino-2 ethyl)-3 indole [French]; Tryptamine, 98%; BRN 0125513; 2-(1H-INDOL-3-YL)-ETHYLAMINE; EINECS 200-510-5; CHEMBL6640; 422ZU9N5TV; CHEBI:16765; APJYDQYYACXCRM-UHFFFAOYSA-N; Tryptamine, free base; 3-[2-Aminoethyl]indole; beta-(3-Indolyl)ethylamine; triptamine; CCRIS 8959; SR-01000075589; 3-Indoleethanamine; 3-indolylethylamine; TSH; PubChem9450; (3-Indolyl)ethylamine; Spectrum_000033; ACMC-209mtp; Spectrum2_000873; Spectrum3_001890; Spectrum4_000850; Spectrum5_001296; 2-indol-3-yl-ethylamine; 2-Indol-3-yl-aethylamin; 3-(2-amino)ethyl indole; bmse000207; EC 200-510-5; Lopac-246557; 3-(beta-aminoethyl)-indole; Lopac0_000061; Oprea1_870097; SCHEMBL26725; BSPBio_003400; GTPL125; KBioGR_001459; KBioSS_000393; 5-22-10-00045 (Beilstein Handbook Reference); KSC354A2B; MLS000515794; DivK1c_000862; SPECTRUM1503922; SPBio_000945; .beta.-(3-Indolyl)ethylamine; Tryptamine, analytical standard; 3-(2-Aminoethyl)-1H-indole; DTXSID2075340; SCHEMBL13006684; 2-(1h-indol-3-yl) ethylamine; CTK2F4020; HMS502L04; KBio1_000862; KBio2_000393; KBio2_002961; KBio2_005529; KBio3_002903; NINDS_000862; [2-(1h-indol-3-yl)ethyl]amine; 2-(1H-indol-3-yl)-ethyl-amine; HMS1922K18; HMS2267B18; ZINC120144; 2-(1H-Indol-3-yl)ethanamine #; ACN-F000556; ACT09907; ALBB-017957; BCP21605; CS-D1750; EBD10651; HY-B2132; ANW-33851; BBL015353; BDBM50024210; CCG-40088; HTS028111; s3627; SBB003963; STK262895; AKOS000119468; ACN-000556; ACN-036699; DB08653; FS-3317; MCULE-6402431765; RTC-066345; SDCCGMLS-0066798.P001; SDCCGSBI-0050049.P003; TRA0076983; VI30132; IDI1_000862; NCGC00014994-01; NCGC00014994-02; NCGC00014994-03; NCGC00014994-04; NCGC00014994-05; NCGC00014994-06; NCGC00014994-07; NCGC00095081-01; NCGC00095081-02; NCGC00095081-03; NCGC00095081-04; NCGC00095081-05; AM807158; BP-12561; BR-80344; LS-82268; SC-05762; SMR000112268; SY001383; AB0007015; AB1001199; DB-005731; ST2409261; TC-066345; Tryptamine, Vetec(TM) reagent grade, 98%; FT-0081340; FT-0613523; ST50308344; T0890; V2315; (Amino-2 ethyl)-3 indole; 3-Indoleethylamine; AZ0001-0257; C00398; M-3012; T-8095; T-8100; 005T661; 2-(3-Indolyl)ethylamine; 3-(2-Aminoethyl)indole; AE-848/30735051; L000946; Q409439; SR-01000075589-5; BRD-K44218819-001-05-1; F2169-0960; 5E7B376B-5933-446C-9D88-661B5F480122; InChI=1/C10H12N2/c11-6-5-8-7-12-10-4-2-1-3-9(8)10/h1-4,7,12H,5-6,11H; Tryptamine; 5-22-10-00045 (Beilstein Handbook Reference)
Tubercidin 7-beta-D-Ribofuranosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine; tubercidin; 7-Deazaadenosine; 69-33-0; Sparsomycin A; Tubercidine; Antibiotic XK 101-1; UNII-M351LCX45Y; SKI 26996; 7-Deazadenosine; 7-deaza-adenosine; EINECS 200-703-4; Adenosine, 7-deaza-; Antibiotic 155B2T; BRN 0038498; sparsamycin A; AI3-52353; CHEMBL267099; M351LCX45Y; CHEBI:48267; 7H-Pyrrolo(2,3-d)pyrimidine, 4-amino-7-beta-D-ribofuranosyl-; U10071; U-10071; 4-Amino-7-(beta-D-ribofuranosyl)-pyrrolo(2,3-d)pyrimidine; 4-Amino-7-beta-D-ribofuranosyl-7H-pyrrolo(2,3-d)pyrimidine; 4-Amino-7beta-D-ribofuranosyl-7H-pyrrolo(2,3-d)pyrimidine; 7-beta-D-Ribofuranosyl-7H-pyrrolo(2,3-d)pyrimidine-4-amine; 7beta-D-Ribofuranosyl-7H-pyrrolo(2,3-d)pyrimidine-4-amine; 7H-Pyrrolo(2,3-d)pyrimidin-4-amine, 7-beta-D-ribofuranosyl-; 7H-Pyrrolo(2,3-d)pyrimidine, 4-amino-7beta-D-ribofuranosyl-; NSC 56408; 7-(beta-D-ribofuranosyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine; 7-beta-CD-ribofuranosyl-7H-pyrrolo(2,3-d)pyrimidin-4-amine; U 10071; B 120121; 2-(4-Amino-pyrrolo[2,3-d]pyrimidin-7-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol; (2R,3R,4S,5R)-2-(4-amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; Deazaadenosine; AK163027; 7-Deaza-rA; 1pr5; cid_6245; SCHEMBL8259; 4-26-00-01117 (Beilstein Handbook Reference); MLS001074702; BIDD:GT0715; GTPL4755; HDZZVAMISRMYHH-KCGFPETGSA-N; 7-beta-D-Ribofuranosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine; HMS2269L05; EX-A1062; KS-00000H8T; ZINC3832269; BDBM50000298; MFCD00056012; ACN-040819; API0008481; CS-5578; DB03172; NCGC00163638-01; SMR000471894; AX8156053; HY-100126; LS-139541; ST24045647; X7273; SR-01000765501; Tubercidin, from Streptomyces tubercidicus, ~95%; SR-01000765501-3; Q27089034; 4-Amino-7-(b-D-ribofuranosyl)pyrrolo[2,3-d]pyrimidine; 4-Amino-7 beta-D-ribofuranosyl-7H-pyrrolo(2,3-d)pyrimidine; 7-beta-D-ribofuranosyl-7H-pyrrolo-(2,3-d)pyrimidin-4-amine; 7-beta-D-ribofuranosyl-7H-pyrrolo-(2,3-d)pyrimidin-4-amine (9CI); (2R,3R,4S,5R)-2-(4-Amino-pyrrolo[2,3-d]pyrimidin-7-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol; (2R,3R,4S,5R)-2-(4-aminopyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; (2R,3R,4S,5R)-2-{4-amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl}-5-(hydroxymethyl)oxolane-3,4-diol; 2-(4-Amino-pyrrolo[2,3-d]pyrimidin-7-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol (Tubercidin); 2-(4-Amino-pyrrolo[2,3-d]pyrimidin-7-yl)-5-hydroxymethyl-tetrahydro-furan-3,4-diol(tubercidin); Tubercidin; B 120121
Tuberculosis/mycobacterial diseases drugs
Tubocurarine chloride (13aR,25aS)-2,3,13a,14,15,16,25,25a-Octahydro-9,19-dihydroxy-18,29-dimethoxy-1,14,14-trimethyl-13H-4,6:21,24-Dietheno-8,12-metheno-1H-pyrido[3',2':14,15][1,11]dioxacycloeicosino[2,3,4-ij]isoquinolinium; Tubocurarine; HSDB 2152
Tunicamycin
Tylosin Tylosin; Tylocine; Tylosine; tylosin tartrate; TilosiTylosinum; 1401-69-0; Tylosin A; Fradizine; Tylan; UNII-YEF4JXN031; YEF4JXN031; CHEBI:17658; Vubityl 200; Tylosine [INN-French]; Tylosinum [INN-Latin]; Tilosina [INN-Spanish]; HSDB 7022; EINECS 215-754-8; AI3-29799; SR-05000002057; Tylosin [USP:INN:BAN]; Tylan (TN); Tylosin (USP/INN); SCHEMBL3081; BSPBio_003548; CHEMBL42743; SPECTRUM1505312; SCHEMBL16931534; HY-B0519A; WBPYTXDJUQJLPQ-VMXQISHHSA-N; HMS1922B22; HMS2093B11; Pharmakon1600-01505312; (10E,12E)-(3R,4S,5S,6R,8R,14S,15R)-14-((6-deoxy-2,3-di-O-methyl-beta-D-allopyranosyl)oxymethyl)-5-((3,6-dideoxy-4-O-(2,6-dideoxy-3-C-methyl-alpha-L-ribo-hexopyranosyl)-3-dimethylamino-beta-D-glucopyranosyl)oxy)-6-formylmethyl-3-hydroxy-4,8,12-trimethyl-9-oxoheptadeca-10,12-dien-15-olide; Antibiotic obtained from cultures of Streptomyces fradiae, or the same substance produced by any other means; CCG-38343; LMPK04000004; NSC758961; s5108; ZINC238809556; ZINC252441679; CS-3442; DB11475; NSC-758961; (10E,12E)-(3R,4S,5S,6R,8R,14S,15R)-14-((6-deoxy-2,3-di-O-methyl-beta-D-allopyranosyl)oxymethyl)-5-((3,6-dideoxy-4-O-(2,6-dideoxy-3-C-methyl-alpha-l-ribo-hexopyranosyl)-3-dimethylamino-beta-d-glucopyranosyl)oxy)-6-formylmethyl-3-hydroxy-4,8,12-trimet; 2-[(4R,5S,6S,7R,9R,11E,13E,15R,16R)-6-[(2R,3R,4R,5S,6R)-5-[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyloxan-2-yl]oxymethyl]-5,9,13-trimethyl-2,10-dioxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde; E713; SBI-0206754.P001; C01457; D02490; AB00959655_03; AB00959655_04; Q411462; SR-05000002057-1; SR-05000002057-2; SR-05000002057-3; BRD-K37753391-046-03-2; [(2R,3R,4E,6E,9R,11R,12S,13S,14R)-12-[3,6-dideoxy-4-O-(2,6-dideoxy-3-C-methyl-alpha-L-ribo-hexopyranosyl)-3-(dimethylamino)-beta-D-glucopyranosyloxy]-2-ethyl-14-hydroxy-5,9,13-trimethyl-8,16-dioxo-11-(2-oxoethyl)oxacyclohexadeca-4,6-dien-3-yl]methyl 6-deoxy-2,3-di-O-methyl-beta-D-allopyranoside; [(2R,3R,4E,6E,9R,11R,12S,13S,14R)-12-{[3,6-dideoxy-4-O-(2,6-dideoxy-3-C-methyl-alpha-L-ribo-hexopyranosyl)-3-(dimethylamino)-beta-D-glucopyranosyl]oxy}-2-ethyl-14-hydroxy-5,9,13-trimethyl-8,16-dioxo-11-(2-oxoethyl)oxacyclohexadeca-4,6-dien-3-yl]methyl 6-deoxy-2,3-di-O-methyl-beta-D-allopyranoside; Tylosin; 1401-69-0; 847659-38-5; Tylosin; 1401-69-0; AK115101; ZINC250255683; Tylosin; 1401-69-0; SCHEMBL3080; DTXSID3043996; Tylosin; Tylan; Tylon; Frazidine; Parkenova; Dehydrorelomycin; Corvel-Tylocine; Elanco-M; Norco T-2; SCHEMBL4567042; WBPYTXDJUQJLPQ-LLMNDNAOSA-N; 1401-69-0; Tylosin; Tylosin A; Fradizine; Tylan; Vubityl 200; Tylosine [INN-French]; Tylosinum [INN-Latin]; Tilosina [INN-Spanish]; HSDB 7022; EINECS 215-754-8; AI3-29799; Tylosin [INN:BAN]; 1401-69-0; Tylosin Tartrate (Salt); (10E,12E)-(3R,4S,5S,6R,8R,14S,15R)-14-((6-deoxy-2,3-di-O-methyl-beta-D-allopyranosyl)oxymethyl)-5-((3,6-dideoxy-4-O-(2,6-dideoxy-3-C-methyl-alpha-L-ribo-hexopyranosyl)-3-dimethylamino-beta-D-glucopyranosyl)oxy)-6-formylmethyl-3-hydroxy-4,8,12-trimethyl-9-oxoheptadeca-10,12-dien-15-olide; Antibiotic obtained from cultures of Streptomyces fradiae, or the same substance produced by any other means; LS-158232; Tylosin; 1401-69-0; HMS3714K03; CCG-220691; ST24050333; Q-201909; Tylosin; 1401-69-0; AKOS015961863; AC-15162; Tylosin; Tylan; Tylon; 6S,1R,3R,9R,10R,14R)-9-[((5S,3R,4R,6R)-5-hydroxy-3,4-dimethoxy-6-methylperhydropyran-2-yloxy)methyl]-10-ethyl-14-hydroxy-3,7,15-trimethyl-11-oxa-4,12-dioxocyclohexadeca-5,7-dienyl}ethanal; Oxacyclohexadeca-11,13-diene-7-acetaldehyde, 15-[[(6-deoxy-2,3-di-O-methyl-b-D-allopyranosyl)oxy]methyl]-6-[[3,6-dideoxy-4-O-(2,6-dideoxy-3-C-methyl-a-L-ribo-hexopyranosyl)-3-(dimethylamino)-b-D-glucopyranosyl]oxy]-16-ethyl-4-hydroxy-5,9,13-trimethyl-2,10-dioxo-, [4R-(4R*,5S*,6S*,7R*,9R*,11E,13E,15R*,16R*)]-; Tylosin; 1401-69-0; (12Z)-Tyrosine [antibiotic]; Tylosin; tylosin tartrate; 1401-69-0; Tylosin; 1401-69-0; Tylosin; 1401-69-0; AK115101; Tylosin; 1401-69-0; Tylosin; 1401-69-0; ZINC669679166; Tylosin; 1401-69-0; Tylosin; Tylosin A; 1401-69-0; BCP11970; AI3-29799
Tyramine 4-(2-Aminoethyl)phenol; Tyramine; 4-(2-Aminoethyl)phenol; 51-67-2; p-Tyramine; 4-Hydroxyphenethylamine; 2-(4-Hydroxyphenyl)ethylamine; Uteramine; Tocosine; Tyramin; Tyrosamine; 4-Hydroxyphenylethylamine; Phenol, 4-(2-aminoethyl)-; Systogene; p-(2-Aminoethyl)phenol; p-Hydroxyphenethylamine; Tenosin-wirkstoff; p-Hydroxyphenylethylamine; 2-(p-Hydroxyphenyl)ethylamine; Phenethylamine, p-hydroxy-; p-beta-Aminoethylphenol; Phenol, p-(2-aminoethyl)-; Benzeneethanamine, 4-hydroxy-; Tyramine base; beta-Hydroxyphenylethylamine; NSC 249188; alpha-(4-Hydroxyphenyl)-beta-aminoethane; UNII-X8ZC7V0OX3; BRN 1099914; HSDB 2132; EINECS 200-115-8; MFCD00008193; p-.beta.-Aminoethylphenol; 4-(2-aminoethyl)-Phenol; X8ZC7V0OX3; CHEMBL11608; MLS000079096; 4-Hydroxy-beta-phenylethylamine; p-Hydroxy-.beta.-phenethylamine; 2-(4'-Hydroxyphenyl)ethylamine; beta-(4-Hydroxyphenyl)ethylamine; CHEBI:15760; 4-Hydroxy-.beta.-phenylethylamine; DZGWFCGJZKJUFP-UHFFFAOYSA-N; .beta.-(4-Hydroxyphenyl)ethylamine; Tyramine, free base; NSC249188; Tyramine, 97%; NSC-249188; NCGC00016011-08; SMR000059295; para-Tyramine; .alpha.-(4-Hydroxyphenyl)-.beta.-aminoethane; DSSTox_CID_23874; DSSTox_RID_80079; DSSTox_GSID_43874; CAS-51-67-2; [3H]tyramine; [3H]-Tyramine; SR-01000075365; L-Tyramine; 4-aminoethylphenol; AEF; MFCD00149002; Tyramine, 99%; Spectrum_001213; Opera_ID_887; Tyramine, 98%, FG; p-hydroxy-phenylethylamine; Spectrum2_000738; Spectrum3_000693; Spectrum4_001801; Spectrum5_000501; Lopac-T-2879; p-(2-aminoethyl)-Phenol; 4-Hydroxy phenylethylamine; ACMC-1AQH1; P-hydroxy-b-phenethylamine; Biomol-NT_000075; bmse000243; bmse000870; bmse000891; 4-hydroxy-Benzeneethanamine; (4-hydroxyphenyl)ethylamine; cid_5610; SCHEMBL4111; WLN: Z2R DQ; 4-(2-amino-ethyl)-phenol; P-hydroxy-b-phenylethylamine; 4- (2-aminoethyl)-Phenol; 4-Hydroxy-b-phenylethylamine; Lopac0_001136; Oprea1_294339; BSPBio_002445; KBioGR_002405; KBioSS_001693; p-Hydroxy-beta-phenethylamine; SPECTRUM210400; Tyramine, analytical standard; 4-13-00-01788 (Beilstein Handbook Reference); KSC269I3J; b-(4-Hydroxyphenyl)ethylamine; BIDD:ER0507; DivK1c_000918; 2-(4-hydroxyphenyl)ethanamine; SPBio_000696; p-Hydroxy-beta-phenylethylamine; BPBio1_001394; GTPL2148; GTPL2150; SGCUT00017; ZINC2233; 2-(4-hydroxy-phenyl)ethylamine; 2-(4-Hydroxyphenyl)-ethylamine; DTXSID2043874; FEMA NO. 4215; BDBM29135; CTK1G9434; HMS502N20; KBio1_000918; KBio2_001693; KBio2_004261; KBio2_006829; KBio3_001665; KS-00000NMU; NINDS_000918; p-Hydroxy-.beta.-phenylethylamine; HMS1923C19; HMS2235J05; a-(4-Hydroxyphenyl)-b-aminoethane; to_000085; 4-(2-Aminoethyl)-phenol(thyramin); Tox21_110282; ANW-31318; BBL027695; CCG-39684; s3625; STK531130; AKOS000156022; Tox21_110282_1; CS-W007606; DB08841; HY-W007606; MCULE-3986856320; RTC-060462; SDCCGSBI-0051103.P003; TRA0098101; IDI1_000918; NCGC00016011-01; NCGC00016011-02; NCGC00016011-03; NCGC00016011-04; NCGC00016011-05; NCGC00016011-06; NCGC00016011-07; NCGC00016011-09; NCGC00016011-10; NCGC00016011-11; NCGC00016011-12; NCGC00016011-14; NCGC00016011-16; NCGC00063825-04; NCGC00063825-05; NCGC00063825-06; NCGC00063825-07; NCGC00063825-08; AK-47332; AS-11671; BR-47332; SC-15191; SY002127; Tyramine, Vetec(TM) reagent grade, 99%; alpha.-(4-Hydroxyphenyl)-beta-aminoethane; AB0010532; LS-103895; LS-103913; TC-060462; A0302; AM20060645; FT-0651978; ST24033343; ST51037693; 51T672; C00483; M-3365; T-8910; T-8911; 21758-EP2281563A1; 21758-EP2298312A1; 21758-EP2314571A2; AB00051887-15; Q165930; SR-01000075365-5; BRD-K53893978-001-03-1; 4-(1,1,3,3-Tetramethylbutyl)phenol polymer with formaldehyde and oxirane; InChI=1/C8H11NO/c9-6-5-7-1-3-8(10)4-2-7/h1-4,10H,5-6,9H; Tyramine; 4-13-00-01788 (Beilstein Handbook Reference)
Uracil uracil; 66-22-8; 2,4-Dihydroxypyrimidine; 2,4(1H,3H)-Pyrimidinedione; 2,4-Pyrimidinediol; pyrimidine-2,4(1H,3H)-dione; 2,4-Dioxopyrimidine; 2,4-Pyrimidinedione; Pirod; Pyrod; pyrimidine-2,4-diol; Hybar X; 1H-Pyrimidine-2,4-dione; 51953-14-1; RU 12709; Ura; Uracil [USAN]; 1,2,3,4-tetrahydropyrimidine-2,4-dione; CCRIS 3077; Urazil; 2-Hydroxy-4(3H)-pyrimidinone; SQ 6201; SQ 7726; SQ 8493; BMS 205603-01; AI3-25470; UNII-56HH86ZVCT; NSC 3970; 2,4-Pyrimidinediol (9CI); 2-Hydroxy-4(1H)-pyrimidinone; CHEBI:17568; Fluorouracil Impurity C; EINECS 200-621-9; MFCD00006016; pyrimidinedione; 56HH86ZVCT; 4-Hydroxy-2(1H)-pyrimidinone; NSC3970; ISAKRJDGNUQOIC-UHFFFAOYSA-N; 4(3H)-Pyrimidinone, 2-hydroxy-; NSC-3970; 144104-68-7; SQ-6201; SQ-7726; SQ-8493; Uracil-5-d; NCGC00181030-01; BMS-205603-01; Uracil, 99+%; DSSTox_CID_1424; DSSTox_RID_76153; DSSTox_GSID_21424; 66255-05-8; 4-Hydroxyuracil; CAS-66-22-8; Uracil (8CI); 24897-50-5; Uracil [USAN:JAN]; Uracyl; 8h-uracil; hydroxypyrimidinone; 2,6-Dioxypyrimidin; Uracil,(S); 2,4-Dioxypyrimidine; Lamivudine impurity e; 2,4(1H,3H)-Pyrimidinedione (9CI); pyrimidine-2,4-dione; PubChem14135; Uracil, 99%; 1ui0; Uracil (JAN/USAN); 2,3H)-Pyrimidinedione; 4(1H)-Pyrimidinone, 2-hydroxy- (9CI); 2,6-Dihydroxypyrimidine; Lamivudine impurity e rs; 2,4-?Dihydroxypyrimidine; ACMC-1AS5O; ACMC-1C4TI; bmse000187; bmse000940; CHEMBL566; Epitope ID:120356; NCIMech_000782; SCHEMBL8235; Uracil, >=99.0%; 51953-20-9; 66224-60-0; KSC352S4R; MLS001304993; GTPL4560; 2,4-(1h,3h)-pyrimidinedione; DTXSID4021424; CTK1G3699; CTK1G8296; CTK1I0613; CTK1J5004; CTK2F2948; Fluorouracil specified compound c; Uracil, >=99.0% (T); 1,3-dihydropyrimidine-2,4-dione; HMS2234E19; HMS3264C13; HMS3373E18; HMS3652N05; Pharmakon1600-01502345; ZINC895045; 2(1H)-Pyrimidinone, 4-hydroxy-; 2(1H)-Pyrimidinone, 6-hydroxy-; BCP26546; HY-I0960; NSC29742; Tox21_112680; Tox21_201023; ANW-31373; ANW-35165; BBL004237; CCG-35866; NSC-29742; NSC759649; s4177; SBB058492; STK301734; STL124066; AKOS000119989; AKOS002303991; Tox21_112680_1; AM83913; CCG-213042; CS-W020104; DB03419; LS-7748; MCULE-1147953020; NSC-759649; PS-5279; KS-0000024N; NCGC00181030-02; NCGC00247663-01; NCGC00258576-01; Uracil, Vetec(TM) reagent grade, 98%; 4CN-0756; AK-86824; NCI60_003718; Pyrimidine-2,4(1H,3H)-dione (Uracil); SC-09054; SC-29470; SMR000752912; AB0008404; DB-030518; DB-103964; TC-120118; BB 0242167; FT-0609769; FT-0694063; ST45061548; SW220239-1; U0013; Uracil, suitable for cell culture, BioReagent; 4177-EP2270010A1; 4177-EP2270015A1; 4177-EP2272832A1; 4177-EP2275420A1; 4177-EP2281563A1; 4177-EP2287152A2; 4177-EP2292593A2; 4177-EP2295055A2; 4177-EP2295408A1; 4177-EP2295414A1; 4177-EP2295416A2; 4177-EP2295434A2; 4177-EP2295441A2; 4177-EP2295503A1; 4177-EP2298748A2; 4177-EP2298764A1; 4177-EP2298765A1; 4177-EP2298778A1; 4177-EP2298783A1; 4177-EP2303848A2; 4177-EP2305219A1; 4177-EP2305642A2; 4177-EP2305684A1; 4177-EP2305808A1; 4177-EP2305825A1; 4177-EP2311453A1; 4177-EP2311815A1; 4177-EP2311842A2; 4177-EP2316459A1; C00106; D00027; M-6157; X-2151; AB00171810_03; AB00171810_04; AB00918623-05; 142257-EP2272848A1; 142257-EP2292593A2; A835376; AC-907/30002021; Q182990; Z56889474; F1796-0008; E2FC11E5-1887-46DF-B415-82313CE9B2BD; Uracil, United States Pharmacopeia (USP) Reference Standard; Fluorouracil impurity C, European Pharmacopoeia (EP) Reference Standard; InChI=1/C4H4N2O2/c7-3-1-2-5-4(8)6-3/h1-2H,(H2,5,6,7,8; Uracil, Pharmaceutical Secondary Standard; Certified Reference Material; 51953-19-6; 766-19-8; AI3-25470
Urapidil 2,4(1H,3H)-PYRIMIDINEDIONE, 6-[[3-[4-(2-METHOXYP; Urapidil; B-66256
Urethane Carbamic acid, Ethyl ester; Ethyl carbamate; A 11032
Uric acid 7,9-Dihydro-1H-purine-2,6,8(3H)-trione; uric acid; 69-93-2; urate; 2,6,8-trioxypurine; Lithic acid; 2,6,8-trihydroxypurine; 2,6,8-Trioxopurine; 7,9-Dihydro-1H-purine-2,6,8(3H)-trione; 8-hydroxyxanthine; 1H-Purine-2,6,8(3H)-trione, 7,9-dihydro-; 1H-Purine-2,6,8-triol; Purine-2,6,8(1H,3H,9H)-trione; 2,3,6,7,8,9-hexahydro-1H-purine-2,6,8-trione; 7,9-dihydro-3H-purine-2,6,8-trione; AI3-15432; NSC 3975; UNII-268B43MJ25; EINECS 200-720-7; CHEMBL792; 9H-purine-2,6,8-triol; 1H-purine-2,6,8(3H,7H,9H)-trione; CHEBI:17775; LEHOTFFKMJEONL-UHFFFAOYSA-N; NSC-3975; Ammonium urate; MFCD00005712; 268B43MJ25; NCGC00181032-01; 8-Hydroxy-3,9-Dihydro-1h-Purine-2,6-Dione; 6,8-Dioxo-6,7,8,9-tetrahydro-1H-purin-2-olate; trioxopurine; URC; Lithate; hypoxanthinediol; C5H4N4O3; 2,8-Trioxopurine; 2,8-Trioxypurine; 8HX; URICACID; Uric acid (8CI); 2,8-Trihydroxypurine; Uric acid, 99+%; 1l5s; ACMC-209obr; 2,6,8-trihydroxypurin; Purine-2,6,8-triol; 1H-Purine-2,8-triol; Uric acid, 99.0%; bmse000126; H-Purine-2,6,8-triol; SCHEMBL7933; 7H-purine-2,6,8-triol; DSSTox_CID_22508; DSSTox_RID_80044; DSSTox_GSID_42508; ARONIS25145; C5NH44O3; GTPL4731; DTXSID3042508; SCHEMBL15777793; SCHEMBL17081907; CHEBI:46811; CHEBI:46814; CHEBI:46817; CHEBI:46823; CHEBI:62589; CTK3J1692; CTK8E5591; KS-00000WXE; NSC3975; Uric acid, >=99%, crystalline; HMS3604N17; BCP28980; HY-B2130; Purine-2,8(1H,3H,9H)-trione; ZINC2041003; Tox21_113563; 2094AH; 7355AF; ANW-35797; BDBM50325824; s3955; STL185577; 1,3,7-trihydropurine-2,6,8-trione; AKOS000118731; Purine-3,6,8(1H,3H,9H)-trione; ACN-049285; DB08844; MCULE-3320087210; NE10407; Uric acid, NIST(R) SRM(R) 913b; CAS-69-93-2; KS-0000471X; purine-2,6,8-(1H,3H,9H)-trione; Uric acid, BioXtra, >=99% (HPLC); AS-56119; 6-hydroxy-1H-purine-2,8(7H,9H)-dione; DB-055359; LS-160798; 2,6-dihydroxy-7,9-dihydro-8H-purin-8-one; CS-0020287; FT-0631301; ST45053931; U0018; 1H-Purine-2,8(3H)-trione, 7,9-dihydro-; 7,9-Dihydro-3H-purine-2,6,8-trione(Urate); C00366; U-6050; 1H-Purine-2,6,8-triol 2,6,8-Trihydroxypurine; 69526-EP2295435A1; 69526-EP2308861A1; 7,9-Dihydro-3H-purine-2,6,8-trione(uric acid); Q105522; SR-01000945208; SR-01000945208-1; 565FF3AF-8AFA-4EE9-9FC4-6B119784A5BB; 1H-Purine-2,6,8(3H)-trione, 7,9-dihydro- (9CI); Z1318255135; 13154-20-6; InChI=1/C5H4N4O3/c10-3-1-2(7-4(11)6-1)8-5(12)9-3/h(H4,6,7,8,9,10,11,12; AI3-15432
Uridine uridine; 58-96-8; Uridin; Uracil riboside; 1-beta-D-Ribofuranosyluracil; beta-Uridine; NSC 20256; d-uridine; CHEBI:16704; b-Uridine; Uracil, 1-beta-D-ribofuranosyl-; UNII-WHI7HQ7H85; Urd; AI3-52690; EINECS 200-407-5; WHI7HQ7H85; MLS000069625; 1-.beta.-D-Ribofuranosyluracil; C9H12N2O6; DRTQHJPVMGBUCF-XVFCMESISA-N; SMR000058222; uridine-1'-13C; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione; 1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione; 1-beta-D-ribofuranosylpyrimidine-2,4(1H,3H)-dione; MFCD00006526; 1-((2R,3R,4S,5R)-tetrahydro-3,4-dihydroxy-5-(hydroxymethyl)furan-2-yl)pyrimidine-2,4(1H,3H)-dione; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione; 1-[(4S,2R,3R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3-dihydropyrimi dine-2,4-dione; 3083-77-0; araU; NSC20256; Uracil-1-beta-d-ribofuranoside; Uridine-t; NSC-20256; d-Ribosyl uracil; .beta.-Uridine; Uridine,(S); uridine-3-15N; PubChem6944; 201996-62-5; 1af2; 4jx9; 4pd6; Opera_ID_118; Uridine, >=99%; uridine-1,3-15N2; 1-b-D-Ribofuranosyluracil; 1-A-D-Ribofuranosyluracil; bmse000158; bmse000816; bmse000864; Epitope ID:149164; 1-.beta.-D-Ribofuranosyl-2,4(1H,3H)-pyrimidinedione; beta-D-ribofuranosyl-uridine; SCHEMBL20667; Uracil-1-b-D-ribofuranoside; Uracil-1-A-D-ribofuranoside; KSC270I9P; rg2417; Uridine, BioUltra, >=99%; CHEMBL100259; GTPL4566; 1-beta-delta-Ribofuranosyluracil; CTK1H0497; KS-00000MQX; BIU0400; DTXSID40891555; Uracil-1-.beta.-d-ribofuranoside; ZX-AFC000720; HMS2230P13; HY-B1449; ZINC2583633; ZX-AT005367; ANW-33100; BDBM50088517; GP7250; s2029; SBB000838; AKOS015896922; AM83934; CCG-214447; CS-5153; DB02745; NUC0002780; OR18386; SMP1_000029; NCGC00017312-02; NCGC00017312-04; NCGC00142368-01; BR-47314; DS-14345; SRI-10895_12; ST023512; Uridine, Vetec(TM) reagent grade, 99%; DB-030519; LS-158705; FT-0082887; U0020; KS-00000243; C00299; M-6784; 16500-EP2269990A1; 16500-EP2270006A1; 16500-EP2281563A1; 16500-EP2287165A2; 16500-EP2287166A2; 16500-EP2292088A1; 16500-EP2292620A2; 16500-EP2292630A1; 16500-EP2295407A1; 16500-EP2295426A1; 16500-EP2295427A1; 16500-EP2295441A2; 16500-EP2298736A1; 16500-EP2305808A1; 16500-EP2308842A1; 16500-EP2316459A1; 1-b-D-Ribofuranosyl-2,4(1H,3H)-pyrimidinedione; b-D-Ribofuranoside 2,4(1H,3H)-pyrimidinedione-1; Q422573; BRD-K13050303-001-18-1; Uridine, powder, BioReagent, suitable for cell culture; .beta.-D-Ribofuranoside, 2,4(1H,3H)-pyrimidinedione-1; 1-beta-delta-Ribofuranosyl-2,4(1H,3H)-pyrimidinedione; 6B6FA3F8-70A2-44EA-B99C-D35D0A9237AA; beta-delta-Ribofuranoside 2,4(1H,3H)-pyrimidinedione-1; 1-beta-D-Ribofuranosylpyrimidine-2,4(1H,3H)-dione (Uridine); Uridine, United States Pharmacopeia (USP) Reference Standard; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione; 162660-19-7; 69-75-0; 92487-68-8; Uridine, PharmaGrade, Manufactured under appropriate controls for use as a raw material in pharma or biopharmaceutical production; AI3-52690
Uridine 5'-triphosphate Uridine 5'-(tetrahydrogen triphosphate); Uridine triphosphate; 4-24-00-01222 (Beilstein Handbook Reference)
Uridine-5'-monophosphate 5'-Uridylic acid; Uridine monophosphate; 5-24-06-00173 (Beilstein Handbook Reference)
Vaccine unspecified (AI) Vaccine unknown; Vaccine generic; Vaccine unknown; Vaccines unspecified; Vaccines generic; Vaccines
Valproic acid 2-Propylpentanoic acid; Valproic acid; 44089
Valsartan N-(1-Oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine; valsartan; 137862-53-4; Diovan; Tareg; Provas; CGP 48933; CGP-48933; Exforge; L-Valsartan; (S)-2-(N-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)pentanamido)-3-methylbutanoic acid; UNII-80M03YXJ7I; N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine; CHEMBL1069; (2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid; 80M03YXJ7I; CHEBI:9927; C24H29N5O3; N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-L-valine; Kalpress; Miten; Nisis; Vals; (S)-N-valeryl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine; (s)-2-(n-((2'-(1h-tetrazol-5-yl)biphenyl-4-yl)methyl)pentanamido)-3-methylbutanoic acid; L-Valine, N-(1-oxopentyl)-N-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-; 137863-60-6; N-[p-(o-1H-Tetrazol-5-ylphenyl)benzyl]-N-valeryl-L-valine; Valzaar; Valtan; Valsartan [USAN:INN]; [3H]valsartan; L-Valine, N-(1-oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-; SMR000466318; Diovan (TN); Prexxartan; Valpression; Varexan; HSDB 7519; L-Valine, N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-; Valsartan [USAN:USP:INN:BAN]; Valsartan,(S); (2S)-3-Methyl-2-(pentanoyl-((4-(2-(2H-tetrazol-5-yl)phenyl)phenyl)methyl)amino)butanoic acid; (2S)-3-methyl-2-[pentanoyl-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid; AK-58790; valsartan (Diovan); MFCD00865840; PubChem9865; Spectrum_001796; N-valeryl-N-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)valine; Spectrum2_001120; Spectrum3_001831; Spectrum4_000749; Spectrum5_001582; Prexxartan (oral solution); EC 604-045-2; SCHEMBL2542; BSPBio_003501; GTPL593; KBioGR_001078; KBioSS_002289; MLS000759423; MLS001424088; BIDD:GT0345; SPECTRUM1505209; SPBio_001260; GTPL3937; Valsartan (JP17/USAN/INN); Valsartan, >=98% (HPLC); KBio2_002287; KBio2_004855; KBio2_007423; KBio3_003006; KS-00000ISS; EZR-104; VAL-489; ACWBQPMHZXGDFX-QFIPXVFZSA-N; HMS1922L21; HMS2051L12; HMS2093K22; HMS2232F05; HMS3651E04; HMS3715P12; Pharmakon1600-01505209; ACT02671; BCP05184; ZINC3875259; ANW-49040; BDBM50049186; BG0645; GP8514; NSC758927; s1894; AKOS015914315; AKOS015994698; AB07510; AC-4543; AM90287; CCG-101028; CCG-221275; CS-1967; DB00177; DS-1248; KS-1194; MCULE-6728882368; NC00278; NSC-758927; RTR-031794; VA11929; N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-L-valine; BR-58790; CPD000466318; HY-18204; I997; SAM001246581; SC-00971; SBI-0206738.P001; AB0013966; AB2000354; AX8018200; LS-161334; ST2408288; TR-031794; FT-0631156; SW197658-2; V-120; 4997-EP2270011A1; 4997-EP2272841A1; 4997-EP2277879A1; 4997-EP2295406A1; 4997-EP2295422A2; 4997-EP2298772A1; 4997-EP2298776A1; 4997-EP2298779A1; 4997-EP2301923A1; 4997-EP2301931A1; 4997-EP2301936A1; 4997-EP2305219A1; 4997-EP2308562A2; 4997-EP2308839A1; 62V534; D00400; J10013; S-6418; AB00639940-06; AB00639940-08; AB00639940_09; AB00639940_11; Q155472; SR-05000001928; J-007068; SR-05000001928-1; BRD-K45158365-001-02-3; BRD-K45158365-001-05-6; Valsartan, European Pharmacopoeia (EP) Reference Standard; N-Valeryl-N-[2'-(5-tetrazolyl)biphenyl-4-ylmethyl]-L-valine; Valsartan, United States Pharmacopeia (USP) Reference Standard; N-Valeryl-N-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]-L-valine; Valsartan, Pharmaceutical Secondary Standard; Certified Reference Material; (5)-2-{N-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]pentanamido}-3-methylbutanoic acid; (S)-3-Methyl-2-{pentanoyl-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid; 3-Methyl-2-{pentanoyl-[2''-(1H-tetrazol-5-yl)-biphenyl-4-yl]-amino}-butyric acid; L-Valine,N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-3-yl]methyl]- (9CI); N-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-N-pentanoyl-L-valine; N-(1-oxopentyl)-N-[[2'-(1h-tetrazol-5-yl) [1,1'-bi-phenyl]-4-yl]methyl]-l-valine; N-(1-Oxopentyl)-N-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-(L)-valine; N-(1-OXOPENTYL)-N-[[2'-(2H-TETRAZOL-5-YL)[1,1'-BIPHENYL]-4-YL]METHYL]-L-VALINE; N-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-L-valine; Valsartan for peak identification, European Pharmacopoeia (EP) Reference Standard; Valsartan for system suitability, European Pharmacopoeia (EP) Reference Standard; (2S)-3-methyl-2-[N-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoic acid; (2S)-3-methyl-2-[N-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoic acid; (2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid.; (2S)-3-Methyl-2-{N-pentanoyl-N'-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butanoic acid; (s)-3-methyl-2-[N-({4-[2-(2h-1,2,3,4-tetrazol-5-yl) phenyl]phenyl}methyl)pentanamido]butanoic acid; (S)-3-methyl-2-[N-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)pentanamido]butanoic acid; (s)-3-methyl-2-{pentanoyl-[-2'-(1h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid; (S)-3-Methyl-2-{pentanoyl-[2''-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid; (S)-3-Methyl-2-{pentanoyl-[2''-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid; (S)-N-(1-carboxy-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'(1H-tetrazol-5-yl)biphenyl-4-yl-methyl]amine; (S)-N-(1-carboxy-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amine; (S)-N-(1-Carboxy-2-methyl-prop-1-yl)-N-pentanoyl-N-[2'-(1H-tetrazol-5-yl)biphenyl-4-ylmethyl]-amine; 2-{[2''-(2,3-Dihydro-1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-pentanoyl-amino}-3-methyl-butyric acid; 3-Methyl-2-{((S)-pentanoyl)-[2''-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-amino}-butyric acid; Valsartan; Diovan
Valspodar 6-[(2S,4R,6E)-4-Methyl-2-(methylamino)-3-oxo-6-octenoicacid]-7-L-valinecyclosporin A; Valspodar [USAN:INN:BAN]; 3'-Keto-bmt(1)-val(2)-cyclosporin A
Vamidothion Phosphorothioic acid, O,O-Dimethyl S-[2-[[1-methyl-2-(methylamino)-2-oxoethyl]thio]ethyl] ester; Vamidothion; R.P. 10,465
Vancomycin VANCOMYCIN; Vancocin; Vancoled; Vancomycinum; VancomiciVancomycine; 1404-90-6; Vancomycine [INN-French]; Vancomycinum [INN-Latin]; VANCOR; Vancomicina [INN-Spanish]; UNII-6Q205EH1VU; HSDB 3262; EINECS 215-772-6; 6Q205EH1VU; CHEMBL262777; CHEBI:28001; Vancomycin (USP); vancomicin; vanomycin; Vancomycin [USP:INN:BAN]; Vancomycin [USAN:INN:BAN]; C66H75Cl2N9O24; Vancomycin hydrochloride from Streptomyces orientalis; Viomycin derivative; [(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-(2-amino-2-oxo-ethyl)-dichloro-pentahydroxy-[[(2R)-4-methyl-2-(methylamino)pentanoyl]amino]-pentaoxo-[?]carboxylic acid; Glycopeptide Antibiotic; C06689; D00212; Tuberactinomycin Analogue; Prestwick0_000497; Prestwick1_000497; Prestwick2_000497; Mannopeptimycin Glycopeptide; SCHEMBL3177; Chloroorienticin B derivative; Lopac0_001267; N-demethylvancomycin derivative; SPBio_002314; Poly ethylene glycol derivative; DTXSID0042664; MYPYJXKWCTUITO-LYRMYLQWSA-N; ACT02696; HY-B0671; Mannopeptimycin glycopeptide analogue; BDBM50335519; s5784; AKOS030526092; AB22390; CCG-205340; CS-3242; DB00512; SDCCGSBI-0051233.P002; LS-161387; 6465-EP1441224A2; 6465-EP2277898A2; 6465-EP2295402A2; 6465-EP2298762A2; 6465-EP2305657A2; 6465-EP2305662A1; 6465-EP2308479A2; 4-Naphthalen-2-ylmethyl-4,5-dihydro-1H-imidazole; 404V906; Q424027; SR-01000076194-5; BRD-K91065602-003-05-5; (2.2Sp,3.5Sa,2.6Sp)-O4.2,C3.4:C5.4,O4.6:C3.5,C2.7-tricyclo[N-methyl-D-leucyl-3-chloro-(R)-beta-hydroxy-D-tyrosyl-L-asparaginyl-D-2-(4-{[2-O-(3-amino-2,3,6-trideoxy-3-C-methyl-alpha-L-lyxo-hexopyranosyl)-beta-D-glucopyranosyl]oxy}phenyl)glycyl-D-2-(4-hydroxyphenyl)glycyl-3-chloro-(R)-beta-hydroxy-L-tyrosyl-L-2-(3,5-dihydroxyphenyl)glycine]; (S)-3,6-Diamino-hexanoic acid {(3S,9S,12S,15S)-3-((S)-6-hydroxy-2-imino-hexahydro-pyrimidin-4-yl)-9,12-bis-hydroxymethyl-2,5,8,11,14-pentaoxo-6-[1-ureido-meth-(Z)-ylidene]-1,4,7,10,13pentaaza-cyclohexadec-15-yl}-amide; EINECS 215-772-6
Vanillic acid 4-Hydroxy-3-methoxybenzoic acid; Vanillic acid; 4-10-00-01459 (Beilstein Handbook Reference)
Venlafaxine 1-[2-(Dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol; venlafaxine; 93413-69-5; Elafax; D,L-Venlafaxine; VenlafaxiVenlafaxinum; 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexanol; Venlafaxine [INN:BAN]; Venlafaxinum [INN-Latin]; Venlafaxin; Venlafaxina [INN-Spanish]; 1-[2-(Dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol; 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol; Efectin; CHEBI:9943; PNVNVHUZROJLTJ-UHFFFAOYSA-N; HSDB 6699; NCGC00095109-01; Cyclohexanol, 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-; DSSTox_CID_3737; DSSTox_RID_77175; DSSTox_GSID_23737; Venlafexine; VenlafaxineXR; Venlafaxine ER; Cyclohexanol, 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)-, (+-)-; Efectin (TN); Venlafaxine (INN); CAS-93413-69-5; venlafaxine (Effexor); SR-01000762930; Venlafaxine [BAN:INN]; DL-Venlafaxine; Venflaxine EP; Spectrum_001671; Cyclohexanol, 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)-, hydrochloride; SpecPlus_000842; Spectrum2_000542; Spectrum3_000989; Spectrum4_001115; Spectrum5_001516; CHEMBL637; EC 618-944-2; N,N,O-Didesmethylvenlafaxine; SCHEMBL35154; BSPBio_002657; KBioGR_001590; KBioSS_002151; MLS006011859; DivK1c_006938; SPECTRUM1504171; SPBio_000583; GTPL7321; DTXSID6023737; BDBM82071; CTK8F8921; KBio1_001882; KBio2_002151; KBio2_004719; KBio2_007287; KBio3_001877; HMS1922F05; HMS2090F04; HMS2093A12; HMS3714K11; Pharmakon1600-01504171; 1-{2-(dimethylamino)-1-[4-(methyloxy)phenyl]ethyl}cyclohexanol; HY-B0196; Tox21_111425; CCG-39577; N,N-dimethyl-2-(1-hydroxycyclohexyl)-2-(4-methoxyphenyl)ethylamine; NSC_62923; NSC758676; s5655; STK621394; AKOS005555049; Tox21_111425_1; AC-1547; API0004581; AT-6375; CS-2129; DB00285; MCULE-6632261838; NSC-758676; SDCCGSBI-0052740.P003; NCGC00095109-02; NCGC00095109-03; NCGC00095109-04; NCGC00095109-05; NCGC00095109-06; NCGC00095109-08; AK116310; K700; LS-57095; SC-25322; SMR002204138; WY-45655; SBI-0052740.P002; AB1004809; AX8023170; CAS_93413-69-5; CAS_99300-78-4; DB-057399; FT-0642242; ST24037045; C07187; D08670; AB00053751-08; AB00053751-10; AB00053751-11; AB00053751_12; AB00053751_13; 413V695; Q898407; SR-01000762930-3; SR-01000762930-4; BRD-A51714012-001-02-3; BRD-A51714012-003-01-1; 1-[2-dimethylamino-1-(4-methoxylphenyl)ethyl]cyclohexanol; (RS)-1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol; N,N-dimethyl-2-(1-hydroxycyclohexyl)-2-(4-methoxyphenyl)ethylamine; 1-[2-dimethylamino-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol; 1-[(1R)-2-(Dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol; Venlafaxine; Venlafaxina [INN-Spanish]
Venlafaxine hydrochloride 1-[2-(Dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol, Hydrochloride (1:1); Venlafaxine hydrochloride [USAN:USP]; 1-(2-(Dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexanol hydrochloride
Veterinary drugs unspecified (AI)
Vincristine 22-Oxovincaleukoblatine; Vincristine; CCRIS 5763
Vitamin K1 [R-[R*,R*-(E)]]-2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalenedione; 2-Methyl-3-(3,7,11,15-tetramethyl-2-hexadecenyl)-1,4-naphthalened- ione; Antihemorrhagic vitamin
Wortmannin (1S,6bR,9aS,11R,11bR)-11-(Acetyloxy)-1,6b,7,8,9a,10,11,11b octahydro-1-(methoxymethyl)-9a,11b-dimethyl-3H-furo[4,3,2-de]indeno[4,5-h]-2-benzopyran-3,6,9-trione; Wortmannin; 4-19-00-03134 (Beilstein Handbook Reference)
Xolegel rel-1-[4-[4-[[(2R,4S)-2-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]ethanone; Ketoconazole; R 41400
Yohimbine (16alpha,17alpha)-17-Hydroxyyohimban-16-carboxylic acid methyl ester; Yohimbine; 4-25-00-01237 (Beilstein Handbook Reference)
Zidovudine THYMIDINE, 3'-AZIDO-3'-DEOXY-; Zidovudine; 3'-Azido-3'-deoxythymidine
Zinc Omadine (T-4)-Bis[1-(hydroxy-kappaO)-2(1H)-pyridinethionato-kappaS2]zinc; Bis(1-hydroxy-2(1H)-pyridinethionato)zinc; AI3-62421
Zucapsaicin (6Z)-N-[(4-Hydroxy-3-methoxyphenyl)methyl]-8-methyl-6-nonenamide; Zucapsaicin [USAN:INN]; BRN 4261852
[Orthoborato(3-)-kappaO]phenylmercurate(2-) hydrogen (1:2) Mercurate(2-), (orthoboroato(3-)-O)phenyl, dihydrogen; Caswell No. 656C
alpha-Hydroxybenzeneacetic acid Benzeneacetic acid, alpha-hydroxy-; Acido mandelico [Italian]
alpha-Naphthoflavone 7,8-Benzoflavone; 7,8-Benzoflavone; alpha-Naphthoflavone; 604-59-1; 2-Phenyl-4H-benzo[h]chromen-4-one; alpha-Naphthylflavone; 2-phenylbenzo[h]chromen-4-one; Benzo(h)flavone; 4H-Naphtho[1,2-b]pyran-4-one, 2-phenyl-; 7,8-BF; 2-Phenyl-benzo[h]chromen-4-one; 2-Phenyl-4H-naphtho(1,2-b)pyran-4-one; .alpha.-Naphthoflavone; CCRIS 3607; 2-Phenylbenzo(h)chromen-4-one; EINECS 210-071-1; UNII-FML65D8PY5; NSC 407011; BRN 0210862; FML65D8PY5; benzo[h]flavone; MLS003171601; CHEMBL283196; CHEBI:76995; VFMMPHCGEFXGIP-UHFFFAOYSA-N; 4H-NAPHTHO(1,2-b)PYRAN-4-ONE, 2-PHENYL-; MFCD00004985; AK122395; N-1500; alpha-Naphthoflavone, 97%; Naphthoflavon; Alpha-Naphtoflavone; BHF; Alpha-Naphtholflavone; PubChem9838; .alpha.-Naphthylflavone; 7,8-Benzoflavone (7CI); Oprea1_054595; Oprea1_802803; 4H-Naphtho[1, 2-phenyl-; 5-17-10-00726 (Beilstein Handbook Reference); BIDD:ER0569; SCHEMBL121594; DTXSID2040650; ZINC38933; HMS3740O15; TNP00080; ZX-AT002210; 9008AB; BDBM50014323; NSC407011; OR1158; 2-phenyl-4-benzo[h][1]benzopyranone; AKOS000505579; CS-W014028; DB07453; MCULE-2454889877; NSC-407011; PS-7270; TRA0030110; 2-Phenyl-4H-benzo[h]chromen-4-one #; KS-0000021Y; NCGC00017210-01; NCGC00017210-02; NCGC00142408-01; CC-24019; LS-95578; SMR000112233; ST055359; 2-PHENYLBENZO(H)-4H-CHROMEN-4-ONE; AX8113561; HY-125833; 4CH-024804; B0056; FT-0622183; S5158; ST24041007; 7,8-BENZOFLAVONE; ALPHA-NAPHTHOFLAVONE; A832737; C-34092; Q4734915; alpha-Naphthoflavone; 5-17-10-00726 (Beilstein Handbook Reference)
alpha-Tocopherol (2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol; alpha-Tocopherol; VITAMIN E; D-alpha-Tocopherol; 59-02-9; 5,7,8-Trimethyltocol; (+)-alpha-Tocopherol; a-Tocopherol; (R,R,R)-alpha-Tocopherol; Eprolin; (2R,4'R,8'R)-alpha-Tocopherol; dl-a-Tocopherol; Tocopherol alpha; alpha-Vitamin E; 10191-41-0; Phytogermine; (2R)-2,5,7,8-TETRAMETHYL-2-[(4R,8R)-4,8,12-TRIMETHYLTRIDECYL]CHROMAN-6-OL; 2074-53-5; Aquasol E; Vitamin Ea; Mixed tocopherols; D-alpha tocopherol; Syntopherol; Denamone; Viteolin; Esorb; Tocopherol (R,S); UNII-N9PR3490H9; alpha Tocopherol; 2,5,7,8-Tetramethyl-2-(4',8',12'-trimethyltridecyl)-6-chromanol; Evitaminum; Profecundin; Waynecomycin; Almefrol; Emipherol; Ephanyl; Epsilan; Etamican; Tokopharm; Vascuals; Viprimol; Vitayonon; Etavit; Ilitia; Evion; 1406-18-4; alpha-Tokoferol; (2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-chromen-6-ol; BPBio1_000362; Vitamin E alpha; Vitaplex E; Eprolin S; Viterra E; CHEBI:18145; E Prolin; Spavit E; GVJHHUAWPYXKBD-IEOSBIPESA-N; ido-E; Endo E; N9PR3490H9; Vita E; EINECS 215-798-8; Lan-E; Med-E; (R)-2,5,7,8-Tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)chroman-6-ol; Antisterility vitamin; alpha-Tocopherol acid; Tenox GT 1; 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-, (2R)-; Rhenogran Ronotec 50; Vi-E; Covitol F 1000; E 307 (tocopherol); DSSTox_CID_6339; (all-R)-alpha-Tocopherol; a-Vitamin E; 3,4-Dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-benzopyran-6-ol; DSSTox_RID_78103; DSSTox_GSID_26339; E-Oil 1000; CCRIS 3588; CCRIS 5853; HSDB 2556; alpha-Tocopherol, D-; EINECS 200-412-2; EINECS 233-466-0; NSC 20812; (2R)-2-((4R,8R)-4,8,12-trimethyltridecyl)-2,5,7,8-tetramethylchroman-6-ol; BRN 0094012; CAS-59-02-9; (+)--tocopherol; 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-, (2R-(2R*(4R*,8R*)))-; 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-, [2R-[2R*(4R*,8R*)]]-; SMR000471844; VIV; (+/-)-alpha-Tocopherol, 95%, synthetic; E 307; (+/-)-alpha-Tocopherol; 3,4-Dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1-benzopyran-6-ol; DL-all-rac-alpha-Tocopherol; Phytogermin; Palmvtee; alpha-Tocoferol; (+-)-Med-E; Vitamin Ealpha; MFCD00072045; a-D-Tocopherol; Pheryl-E; Vita plus E; d-..-Tocopherol; NCGC00016688-02; Vitamin E, liquid; 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)-, (2R)-; Prestwick_653; EINECS 218-197-9; .alpha.-Vitamin E; (+)-a-Tocopherol; NSC 82623; RRR-alpha-tocopherol; RRR-alpha-tocopheryl; Vitamin E (liquid); Vitamin E [USP]; ()-alpha-Tocopherol; delta-alpha-tocopherol; alpha-delta-Tocopherol; Vitamin E (D-form); CHEMBL47; (R,R,R)-a-Tocopherol; DL-all-rac-A-Tocopherol; Prestwick3_000404; (+)-.alpha.-Tocopherol; all-rac-alpha-Tocopherolum; bmse000600; EC 200-412-2; SCHEMBL3097; UNII-H4N855PNZ1; BIDD:PXR0174; D-alpha-Tocopherol, 97+%; BSPBio_000328; MLS001066396; MLS001335981; MLS001335982; BIDD:ER0562; T1539_SIGMA; H4N855PNZ1; DTXSID0026339; (2R,4'R,8'R)-a-Tocopherol; (2R,4'R,8'R)-2,5,7,8-Tetramethyl-2-(4',8',12'-trimethyltridecyl)-6-chromanol; 3,4-Dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-1- -benzopyran-6-ol; HMS2096A10; HMS2231G08; C29H50O2 (D-alpha-tocopherol); HY-N0683; ZINC4095858; Tox21_110563; Tox21_113208; Tox21_202081; LMPR02020001; MFCD00006848; MFCD00072051; AKOS004910417; CS-8161; DB00163; LS-7727; MCULE-3684036705; NCGC00142625-01; NCGC00142625-04; NCGC00142625-05; NCGC00142625-06; NCGC00142625-07; NCGC00142625-10; NCGC00259630-01; (2R*(4R*,8R*))-(1)-3,4-Dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-benzopyran-6-ol; 18920-62-2; AK305272; AS-13990; E307; M349; P500; SC-18444; SC-19194; ST073358; AX8156561; LS-173092; TR-000459; FT-0600386; FT-0624406; C02477; d-alpha, d-beta, d-gamma & d-delta tocopherols; Q158348; Q-201932; W-107596; W-109164; 07AA93F0-3339-4EEC-B50B-ADB70F657087; UNII-7QWA1RIO01 component GVJHHUAWPYXKBD-IEOSBIPESA-N; UNII-N53I4V2IA6 component GVJHHUAWPYXKBD-IEOSBIPESA-N; UNII-R0ZB2556P8 component GVJHHUAWPYXKBD-IEOSBIPESA-N; (+)-alpha-Tocopherol, from vegetable oil, Type V, ~1000 IU/g; (+)-alpha-Tocopherol, Type VI, from vegetable oil, neat (liquid, >=0.88M based on potency, density and molecular wt.), BioReagent, suitable for insect cell culture, >=1000 IU/g; (2R)-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-3,4-dihydro-2H-1-benzopyran-6-ol; (2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol; (R)-2,5,7,8-tetramethyl-2-((4R,8R)-4,8,12-trimethyltridecyl)-3,4-dihydro-2H-chromen-6-ol; 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-, 2R- 2R*(4R*,8R*) -; 2H-1-Benzopyran-6-ol, 3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-, (2R*(4R*,8R*))-(+-)- (9CI); D-alpha tocopherol; E Prolin
beta-Alanine beta-alanine; 107-95-9; 3-Aminopropanoic acid; 3-Aminopropionic acid; H-beta-Ala-OH; Beta Alanine; Abufene; beta-Aminopropionic acid; 2-Carboxyethylamine; .beta.-Alanine; Alanine, beta-; Propanoic acid, 3-amino-; 3-Aminopropionsaeure; beta-Ala; beta-Aminopropionsaeure; omega-Aminopropionic acid; 3-Aminopropanoate; B-ALANINE; 3-amino-propionic acid; FEMA No. 3252; beta-Alaine; AI3-18470; .beta.-Aminopropionic acid; NSC 7603; UNII-11P2JDE17B; beta-Alanine, 99%; EINECS 203-536-5; MFCD00008200; 11P2JDE17B; CHEMBL297569; CHEBI:16958; NSC7603; UCMIRNVEIXFBKS-UHFFFAOYSA-N; beta-alanin; ALANINE, BETA; Alanine-beta; beta- alanine; beta--alanine; b-Aminopropanoate; b-Aminopropionate; beta-Alanine; beta-Alanine #; 3-Aminopropionate; aminopropionic acid; 3-amino-Propanoate; beta-Aminopropanoate; beta-Aminopropionate; A-Ala; Abufene (TN); omega-Aminopropionate; b-Aminopropanoic acid; b-Aminopropionic acid; 14405-06-2; PubChem10996; Tocris-0206; 3-amino-Propanoic acid; beta-Aminopropanoic acid; H2NCH2CH2COOH; H-|A-Ala-OH; H-?-Ala-OH; bmse000159; bmse000967; bmse001019; EC 203-536-5; .omega.-Aminopropionic acid; Oprea1_583450; 87867-95-6; KSC492E8D; beta-Alanine, >=98%, FG; ACMC-1C126; GTPL2365; DTXSID0030823; 3-aminopropanoic acidbeta-alanine; CTK3J2281; beta-Alanine (6CI,8CI,9CI); beta-Alanine, analytical standard; beta-Alanine, Cell Culture Reagent; ACT04890; HY-N0230; NSC-7603; STR03358; ZINC4658555; ANW-15875; BBL037332; BDBM50000102; HTS009046; PDSP1_000144; PDSP2_000143; s5526; STK301638; 3-Aminopropanoic Acid (beta-Alanine); AKOS000119659; CS-W020126; DB03107; MCULE-1344289084; RTC-066646; TRA0045168; KS-000000A8; NCGC00024495-01; NCGC00024495-02; AK-41261; BP-10083; BR-41261; SC-10014; beta-Alanine, BioXtra, >=99.0% (NT); AB1002435; beta-Alanine, BioUltra, >=99.0% (NT); DB-022630; LS-178732; TC-066646; A0180; AM20080020; FT-0622549; ST24032588; C00099; D07561; M-6115; 28674-EP2269992A1; 28674-EP2270002A1; 28674-EP2275102A1; 28674-EP2277865A1; 28674-EP2305660A1; 28674-EP2305687A1; 28674-EP2305808A1; 28674-EP2314579A1; 107A959; Q310919; SR-01000597690; Q-200704; SR-01000597690-1; Z57127544; F2191-0213; 7CA041EF-5103-439A-9D84-1761529BA8DA; beta-Alanine, United States Pharmacopeia (USP) Reference Standard; InChI=1/C3H7NO2/c4-2-1-3(5)6/h1-2,4H2,(H,5,6; Beta Alanine, Pharmaceutical Secondary Standard; Certified Reference Material; beta-Alanine, BioReagent, suitable for cell culture, suitable for insect cell culture; Abufene
beta-Glycerophosphoric acid beta-Glycerophosphate; beta-Glycerophosphoric acid; beta-glycerophosphate; Glycerol 2-phosphate; 17181-54-3; GLYCEROL-2-PHOSPHATE; 1,3-Hydroxy-2-propyl dihydrogen phosphate; 1,2,3-Propanetriol, 2-(dihydrogen phosphate); Glycerophosphoric acid II; 2-glycerophosphate; UNII-WWH06G87W6; glyceryl 2-phosphate; EINECS 241-228-2; 2-HYDROXY-1-(HYDROXYMETHYL)ETHYL DIHYDROGEN PHOSPHATE; WWH06G87W6; CHEBI:17270; glycerylphosphate; glycerinphosphorsaure; beta-Glycerophosphorate; glycerol-beta-phosphate; 58409-70-4; SCHEMBL59773; CHEMBL1232903; DTXSID1023106; CTK8G0070; DHCLVCXQIBBOPH-UHFFFAOYSA-N; glycerol 2-(dihydrogen phosphate); HMS3604K07; ZINC3830897; FCH994554; DB01779; ACM17181543; BB0266004; LS-165126; C02979; [(1,3-dihydroxypropan-2-yl)oxy]phosphonic acid; Q21099098; B9985BAA-A85D-444F-B350-1ADB9CB72031; UNII-MG976Z29OM component DHCLVCXQIBBOPH-UHFFFAOYSA-N; beta-Glycerophosphoric acid; EINECS 241-228-2
beta-Mercaptoethanol 2-Mercaptoethanol; 2-mercaptoethanol; Mercaptoethanol; 60-24-2; Beta-Mercaptoethanol; Thioglycol; Ethanol, 2-mercapto-; 2-Sulfanylethanol; 2-Thioethanol; Thioethylene glycol; Thiomonoglycol; 2-Hydroxyethanethiol; 2-Hydroxyethyl mercaptan; 2-Hydroxy-1-ethanethiol; Monothioglycol; 2-Mercapto-1-ethanol; 1-Ethanol-2-thiol; Hydroxyethyl mercaptan; Monothioethylene glycol; 2-Mercaptoethyl alcohol; 2-ME; Mercaptoetanol; Ethylene glycol, monothio-; 1-Hydroxy-2-mercaptoethane; 1-Mercapto-2-hydroxyethane; 2-Hydroxyethylmercaptan; Emery 5791; USAF EK-4196; Monothioethyleneglycol; beta-Hydroxyethanethiol; 2-sulfanylethan-1-ol; .beta.-Mercaptoethanol; .beta.-Hydroxyethanethiol; beta-Hydroxyethylmercaptan; NSC 3723; UNII-14R9K67URN; 2-mercapto ethanol; CCRIS 2097; HSDB 5199; EINECS 200-464-6; UN2966; .beta.-Hydroxyethylmercaptan; BRN 0773648; AI3-07710; 14R9K67URN; DTXSID4026343; CHEBI:41218; betamercaptoethanol; DGVVWUTYPXICAM-UHFFFAOYSA-N; 2-Mercaptoethanol, 99%, pure; 2-Mercaptoethanol, >=99.0%; 2mercaptoethanol; b-mercaptoethanol; 2-mercapto-ethanol; 2-sulfanyl-ethanol; beta-sulfanylethanol; hydroxyethyl sulfide; mercaptoethyl alcohol; MFCD00004890; 2-Sulfanylethanol #; 2-hydroxy-ethanethiol; 2-mercaptoethan-1-ol; HSCH2CH2OH; WLN: SH2Q; EC 200-464-6; 4-01-00-02428 (Beilstein Handbook Reference); DivK1c_000784; BDBM7971; CHEMBL254951; CTK2F3219; HMS502H06; KBio1_000784; NSC3723; NINDS_000784; Thioglycol [UN2966] [Poison]; KS-000017OG; NSC-3723; Thioglycol [UN2966] [Poison]; ZINC8216595; 2-Mercaptoethanol[forElectrophoresis]; STL482546; 2-Mercaptoethanol, for electrophoresis; AKOS000118900; CCG-231050; DB03345; MCULE-2252943288; UN 2966; IDI1_000784; BP-21398; LS-66846; 2-Mercaptoethanol, for synthesis, 99.0%; DS-014379; TR-020825; FT-0612764; M0058; M1948; 2341-EP2284157A1; 2341-EP2295429A1; 2344-EP2272972A1; 2344-EP2272973A1; 2344-EP2277872A1; 2344-EP2305648A1; C00928; 16605-EP2281563A1; 16605-EP2316459A1; 67670-EP2269996A1; 67670-EP2272972A1; 67670-EP2272973A1; 67670-EP2277872A1; 67670-EP2292597A1; 67670-EP2295414A1; 67670-EP2301627A1; 67670-EP2305808A1; 67670-EP2308839A1; 67670-EP2377849A2; 2-Mercaptoethanol, SAJ special grade, >=99.0%; A832651; Q411084; InChI=1/C2H6OS/c3-1-2-4/h3-4H,1-2H; Q-200296; 3-Pyridinecarbonitrile, 4-methyl-2,6-di-5-morpholinyl-; F0001-1577; 2-Mercaptoethanol, for HPLC derivatization, >=99.0% (GC); 2-Mercaptoethanol, BioUltra, for molecular biology, >=99.0% (GC); 2-Mercaptoethanol, for molecular biology, for electrophoresis, suitable for cell culture, BioReagent, 99% (GC/titration); 2-Mercaptoethanol, PharmaGrade, Manufactured under appropriate controls for use as raw material in pharma or biopharmaceutical production.; 2-mercaptoethanol,beta-mercaptoethanol,2-hydroxy-1-ethanethiol,2-hydroxyethyl mercaptan,monothioethyleneglycol,thioglycol; Mercaptoethanol; 4-01-00-02428 (Beilstein Handbook Reference)
beta-Naphthoflavone 3-Phenyl-1H-naphtho[2,1-b]pyran-1-one; beta-naphthoflavone; 5,6-BENZOFLAVONE; 6051-87-2; beta-NF; 3-Phenyl-1H-naphtho(2,1-b)pyran-1-one; b-naphthoflavone; 3-Phenyl-1H-benzo[f]chromen-1-one; 3-Phenyl-benzo[f]chromen-1-one; 3-Phenyl-1H-naphtho[2,1-b]pyran-1-one; 1H-Naphtho[2,1-b]pyran-1-one, 3-phenyl-; UNII-1BT0256Y8O; 3-phenylbenzo[f]chromen-1-one; CCRIS 3262; .beta.-Naphthoflavone; 1H-Naphtho(2,1-b)pyran-1-one, 3-phenyl-; EINECS 227-958-4; MFCD00004986; NSC 136015; beta-naphthoflavone, 99+%; BRN 0018991; CHEMBL26260; MLS002920345; CHEBI:77013; 1BT0256Y8O; N-1460; BNF; BIDD:ER0570; benzo[f]flavone; WLN: T B666 CV FOJ ER; beta -naphthoflavone; .beta.-Nf; PubChem9837; 3,5-BENZOFLAVONE; DSSTox_CID_10423; DSSTox_RID_78847; DSSTox_GSID_30423; Oprea1_399775; Oprea1_721265; SCHEMBL43538; 1H-Naphtho[2, 3-phenyl-; DTXSID8030423; ZINC57645; OUGIDAPQYNCXRA-UHFFFAOYSA-N; BCP29482; ZX-AT010764; Tox21_302024; BDBM50028963; NSC136015; OR1159; 3-phenyl-1-benzo[f][1]benzopyranone; AKOS025212482; DB06732; LS-2162; NSC-136015; 3-Phenyl-1H-benzo[f]chromen-1-one #; NCGC00188965-01; NCGC00255199-01; AS-56038; CC-24626; SMR001561469; CAS-6051-87-2; TR-035807; 5,6-BENZOFLAVONE(? -NAPHTHOFLAVONE); FT-0622925; N0518; ST50307958; Y2042; A832760; C-34093; Q4897188; beta-NF; 1-b)pyran-1-one,3-phenyl-1h-naphtho(; 5,6-Benzoflavone; beta-Naphthoflavone; 5-17-10-00728 (Beilstein Handbook Reference); 6057-87-2
beta-Resorcylic acid 2,4-Dihydroxybenzoic acid; beta-Resorcylic acid; 4-10-00-01420 (Beilstein Handbook Reference)
cis,cis-Farnesol (2Z,6Z)-3,7,11-Trimethyl-2,6,10-dodecatrien-1-ol; cis,cis-Farnesol; farnesol; (Z,Z)-farnesol; (2Z,6Z)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol; z,z-farnesol; (2-cis,6-cis)-farnesol; UNII-J03523NK03; CRDAMVZIKSXKFV-FBXUGWQNSA-N; J03523NK03; 16106-95-9; 4602-84-0; (2-cis,6-cis)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol; cis-Farnesol; Farnesol, (2Z,6Z)-; FEMA 2478; 2,6,10-Dodecatrien-1-ol, 3,7,11-trimethyl-, (2Z,6Z)-; FEMA No. 2478, (2Z,6Z)-; 3,7,11-Trimethyldodeca-2-cis,6-cis,10-trien-1-ol; SCHEMBL2935434; CHEBI:42680; BCP22706; ZINC13507232; AKOS015901075; cis,cis-Farnesol, >=95.0% (GC); DB02509; LMPR0103010008; FT-0082576; (2Z,6Z)-3,7,11-trimethyl-2,6,10-dodecatrien-1-ol; UNII-EB41QIU6JL component CRDAMVZIKSXKFV-FBXUGWQNSA-N; 2,6,10-Dodecatrien-1-ol, 3,7,11-trimethyl-, (Z,Z)-,; Farnesol, (2Z,6Z)-; UNII-J03523NK03
l-Menthol (1R,2S,5R)-5-Methyl-2-(1-methylethyl)cyclohexanol; l-Menthol; (-)-menthol; 2216-51-5; Levomenthol; Menthacamphor; Menthomenthol; l-(-)-Menthol; Peppermint camphor; (1R,2S,5R)-2-Isopropyl-5-methylcyclohexanol; U.S.P. Menthol; Levomentholum; Menthol racemic; (1r,2s,5r)-(-)-menthol; Hexahydrothymol; d,l-Menthol; (-)-Menthyl alcohol; (-)-(1R,3R,4S)-Menthol; Menthol natural; 89-78-1; (1R)-(-)-Menthol; D-(-)-Menthol; Headache crystals; (R)-(-)-Menthol; Menthol (VAN); l-Menthol (natural); (+-)-Menthol; I-menthol; Racementhol; p-Menthan-3-ol; (-)-trans-p-Menthan-cis-ol; 1-Menthol; Levomenthol [INN:BAN]; Racementhol [INN:BAN]; (L)-MENTHOL; Menthol, dl-; Menthol natural, brazilian; Menthol, l-; Racementol [INN-Spanish]; Levomentholum [INN-Latin]; Menthol racemique [French]; Racementholum [INN-Latin]; Cyclohexanol, 5-methyl-2-(1-methylethyl)-, (1R,2S,5R)-; Tra-kill tracheal mite killer; rac-Menthol; NCI-C50000; UNII-BZ1R15MTK7; NSC 62788; (1R,2S,5R)-5-methyl-2-(propan-2-yl)cyclohexan-1-ol; Menthol, (1R,3R,4S)-(-)-; CCRIS 375; Menthol(-); Racemic menthol; (1R,3R,4S)-(-)-MENTHOL; FEMA No. 2665; CCRIS 3728; CCRIS 4666; (1R,2S,5R)-rel-2-Isopropyl-5-methylcyclohexanol; HSDB 5662; NSC 2603; EINECS 201-939-0; EINECS 218-690-9; EINECS 239-388-3; BRN 1902288; BRN 3194263; BZ1R15MTK7; (+-)-(1R*,3R*,4S*)-Menthol; (1R-(1-alpha,2-beta,5-alpha))-5-Methyl-2-(1-methylethyl)cyclohexanol; menthol crystals; 5-Methyl-2-(1-methylethyl)cyclohexanol; AI3-52408; CHEMBL470670; CHEBI:15409; (1R,2S,5R)-Menthol; NSC2603; (1R,2S,5R)-2-isopropyl-5-methyl-cyclohexanol; NOOLISFMXDJSKH-KXUCPTDWSA-N; (1R,2S,5R)-2-isopropyl-5-methylcyclohexan-1-ol; L(-)-Menthol; MFCD00062979; (1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexanol; (1R,2S,5R)-5-methyl-2-propan-2-ylcyclohexan-1-ol; Cyclohexanol, 5-methyl-2-(1-methylethyl)-, (1R,2S,5R)-rel-; Racementholum; Thymomenthol; Racementol; 5-Methyl-2-(1-methylethyl)cyclohexanol, (1alpha,2beta,5alpha)-; DSSTox_CID_2180; Menthol racemique; Cyclohexanol, 5-methyl-2-(1-methylethyl)-, [1R-(1.alpha.,2.beta.,5.alpha.)]-; DSSTox_RID_75798; DSSTox_RID_76516; DSSTox_GSID_20805; DSSTox_GSID_22180; HSDB 593; L(-)-Menthol, 99.5%; C10H20O; Menthol, cis-1,3,trans-1,4-; (1alpha,2beta,5alpha)-5-methyl-2(1-methylethyl)cyclohexanol; Cyclohexanol, 5-methyl-2-(1-methylethyl)-, (1R,3R,4S)-; Cyclohexanol, 5-methyl-2-(1-methylethyl)-, (1alpha,2beta,5alpha)-; Cyclohexanol, 5-methyl-2-(1-methylethyl)-, (1R-(1alpha,2beta,5alpha))-; CAS-89-78-1; 5-methyl-2-propan-2-ylcyclohexan-1-ol; CAS-2216-51-5; l-Menthol (TN); SR-05000001936; (-)-p-Menthan-3-ol; levomentol; ss-Bisabolol; Laevo-Menthol; 1R-Menthol; 1 -menthol; NCGC00159382-02; 98167-53-4; dextro,laevo-menthol; Water-soluble menthol; Menthol Crystals USP; PubChem7972; Menthol, (1alpha,2beta,5alpha)-Isomer; l-Menthol (JP17); Spectrum_000305; Spectrum2_000855; Spectrum3_001561; Spectrum5_001060; M0545; Menthol,3,trans-1,4-; EC 201-939-0; EC 218-690-9; SCHEMBL4613; BSPBio_003062; KBioSS_000785; 2-06-00-00052 (Beilstein Handbook Reference); 4-06-00-00151 (Beilstein Handbook Reference); MLS002207256; ARONIS27036; DivK1c_000820; SPECTRUM1503134; Menthol,3R,4S)-(-)-; SPBio_000869; GTPL2430; DTXSID1020805; DTXSID1022180; (-)-Menthol, USP, 97%; CTK5H9748; HMS502I22; KBio1_000820; KBio2_000785; KBio2_003353; KBio2_005921; KBio3_002562; NOOLISFMXDJSKH-KXUCPTDWSA-; (-)-Menthol, analytical standard; NINDS_000820; HMS1922G13; HMS2092L14; Pharmakon1600-01503134; CS-M3737; Cyclohexanol, 2-isopropyl-5-methyl; NSC-2603; NSC62788; ZINC1482164; L-Menthol, >=99%, FCC, FG; Tox21_111620; Tox21_201823; Tox21_201919; Tox21_202608; Tox21_302999; Tox21_303028; WLN: L6TJ AY1&1 BQ D1; BDBM50318482; CCG-40300; Cyclohexanol, 2-isopropyl-5-methyl-; NSC-62788; NSC758395; s4714; AKOS016842647; (1R, 2S, 5R-)-(-)-Menthol; BS-3863; DB00825; EBD2156737; LMPR0102090001; LS-2353; MCULE-8181548788; MP-2129; NSC-758395; SDCCGMLS-0066659.P001; 1-iso propyl-4-methyl cyclohexan-2-ol; IDI1_000820; WLN: L6TJ AY1&1 DQ D1 -L; NCGC00164247-01; NCGC00164247-02; NCGC00164247-03; NCGC00256525-01; NCGC00256561-01; NCGC00259372-01; NCGC00259468-01; NCGC00260156-01; D-(-)-Phenylglycine Dane Potassium Salt; HY-75161; LS-89533; SC-02557; SC-18117; SMR001306785; L-Menthol, natural, >=99%, FCC, FG; SBI-0051777.P002; AB1011830; ST2407841; TR-030715; FT-0604399; N1950; S5868; C00400; Cyclohexanol, (1.alpha.,2.beta.,5.alpha.)-; D00064; AB00052320_02; L-Menthol|Levomenthol|Menthomenthol|Menthacamphor; (1R,2S,5R)-(-)-Menthol, >=99%, sublimed; Q407418; Q-201316; SR-05000001936-1; SR-05000001936-2; (-)-Menthol, primary pharmaceutical reference standard; (1R,2S,5R)-(-)-Menthol, ReagentPlus(R), 99%; 2-Isopropyl-5-methylcyclohexanol-, (1R,2S,5R)- #; Cyclohexanol, [1R-(1.alpha.,2.beta.,5.alpha.)]-; (1R,2S,5R)-5-methyl-2-propan-2-yl-cyclohexan-1-ol; Z1698549655; (1R,2S,5R)-(-)-Menthol, Vetec(TM) reagent grade, 98%; 6C6A4A8C-A054-468C-A1F0-F29E39838CF2; UNII-YS08XHA860 component NOOLISFMXDJSKH-KXUCPTDWSA-N; (1R, 2S, 5R)-5-methyl-2-(1-methylethyl)cyclohexyl alcohol; Menthol, United States Pharmacopeia (USP) Reference Standard; L-Menthol, Pharmaceutical Secondary Standard; Certified Reference Material; (-)-Menthol, puriss., meets analytical specification of Ph. Eur., BP, USP, 98.0-102.0%; (1R-(1-.alpha.,2-.beta.,5-.alpha.))-5-Methyl-2-(1-methylethyl)cyclohexanol; (1R,2S,5R)-2-Isopropyl-5-methylcyclohexanol; 5-Methyl-2-(1-methylethyl)cyclohexanol; (-)-p-Menthan-3-ol; (1R,2S,5R)-(?)-Menthol; InChI=1/C10H20O/c1-7(2)9-5-4-8(3)6-10(9)11/h7-11H,4-6H2,1-3H3/t8-,9+,10-/m1/s1; (l)-Menthol; U.S.P. Menthol
m-Aminobenzoic acid 3-Aminobenzoic acid; m-Aminobenzoic acid; 4-14-00-01092 (Beilstein Handbook Reference)
n-Butylamine Butylamine; Butylamine; N-BUTYLAMINE; butan-1-amine; 1-Butanamine; 109-73-9; 1-Aminobutane; 1-Butylamine; Monobutylamine; N-Butylamin; Mono-n-butylamine; Norvalamine; 1-Aminobutan; 1-Amino-butaan; Monobutilamina; Butanamine; butyl amine; n-Butilamina; n-butyl amine; n-Butylamin [German]; Norralamine; n-Butilamina [Italian]; 1-Aminobutan [German]; FEMA Number 3130; Monobutilamina [Romanian]; 1-Amino-butaan [Dutch]; UNII-N2QV60B4WR; NSC 8029; FEMA No. 3130; CCRIS 4756; HSDB 515; EINECS 203-699-2; UN1125; n-C4H9NH2; N2QV60B4WR; AI3-24197; CHEBI:43799; HQABUPZFAYXKJW-UHFFFAOYSA-N; MFCD00011690; n-Butylamine, 99+%; Aminobutane; Butylarnine; n-butyiamine; n-butyl-amine; butane-1-amine; n-butan-1-amine; normal-butyl amine; N-Butylamine NBA; Butylamine, 99%; nBuNH2; 1-Butanamine, 9CI; BuNH2; Aminobutane (Related); n-BuNH2; BUTYLAMINE, N; Butylamine, >=99%; Butylamine, 99.5%; 1-AMINO-BUTANE; 1-Butanaminen-butilamina; DSSTox_CID_1904; EC 203-699-2; DSSTox_RID_76395; NCIOpen2_009229; DSSTox_GSID_21904; WLN: Z4; KSC175M4L; CHEMBL13968; Butylamine, puriss., 99.0%; DTXSID1021904; CTK0H5645; FEMA 3130; KS-00000UWE; NSC8029; ACMC-209948; NSC-8029; STR01992; ZINC1586365; Tox21_301131; ANW-16086; BBL027788; LS-485; STL308736; AKOS000118810; Butylamine, purum, >=98.0% (GC); Butylamine, purum, >=99.0% (GC); DB03659; MCULE-4233278050; RTR-002082; TRA0026534; UN 1125; Butylamine, analytical reference material; Butylamine, puriss., >=99.5% (GC); NCGC00248302-01; NCGC00255030-01; BP-30251; CAS-109-73-9; LYT; TR-002082; B0707; FT-0623326; n-Butylamine [UN1125] [Flammable liquid]; n-Butylamine [UN1125] [Flammable liquid]; 4454-EP2281563A1; 4454-EP2287141A1; 4454-EP2289510A1; 4454-EP2289887A2; 4454-EP2289888A2; 4454-EP2289894A2; 4454-EP2298746A1; 4454-EP2305629A1; 4454-EP2308838A1; 4454-EP2308867A2; 4454-EP2308870A2; 4454-EP2311804A2; 12339-EP2270010A1; 12339-EP2272517A1; 12339-EP2289509A2; 12339-EP2292619A1; 12339-EP2295418A1; 12339-EP2298742A1; 12339-EP2298761A1; 12339-EP2305250A1; 12339-EP2305642A2; 12339-EP2308812A2; 12339-EP2314298A1; 12339-EP2314593A1; 12339-EP2316974A1; 12339-EP2377849A2; 56744-EP2298305A1; 56744-EP2298769A1; 56744-EP2308878A2; Q421035; J-002322; InChI=1/C4H11N/c1-2-3-4-5/h2-5H2,1H; F2190-0358; N-BUTYLAMINE (SEE ALSO: SEC-BUTYLAMINE (CAS 13952-84-6) &TERT-BUTYLAMINE (CAS 75-64-9)); n-Butylamine; AI3-24197
o-Bromophenol 2-Bromophenol; 2-BROMOPHENOL; o-Bromophenol; 95-56-7; Phenol, 2-bromo-; BROMOPHENOL; 2-Bromo-phenol; 2-Bromfenol; Phenol, o-bromo-; o-bromo-phenol; 2-bromo phenol; Phenol, bromo-; 2-Bromfenol [Czech]; NSC 6970; bromophenol, 2-; UNII-A0UB206YF0; 2-Bromophenol, 98%; EINECS 202-432-7; MFCD00002146; BRN 1905115; A0UB206YF0; CHEMBL186007; 2-BROMO-1-HYDROXYBENZENE; VADKRMSMGWJZCF-UHFFFAOYSA-N; ortho-bromophenol; 1-Bromo-2-hydroxybenzene; bromphenol; bromo phenol; bromo-phenol; 2-bromanylphenol; HSDB 7648; ortho-bromo-phenol; EINECS 251-200-1; PubChem3841; 2-Bromophenol 99%; ACMC-209rzf; WLN: QR BE; 1-bromo-2-hydroxy-benzene; DSSTox_CID_31214; 95-56-7 2-bromophenol; CHEMWISH IC03775; DSSTox_GSID_52641; SCHEMBL49313; KSC194K7T; DTXSID8052641; CHEBI:34264; NSC6970; ATTERCOP-CHM AT106043; OTAVA-BB 1287430; 2-Bromophenol, analytical standard; ZINC388200; ACT00737; CS-D1158; KS-00000W4K; NSC-6970; Tox21_303903; ANW-40537; BDBM50150783; STK399784; WT1836; AKOS000121364; AM87485; AS03449; DB04586; LS11447; MCULE-5590917057; PS-5410; RTC-062408; TF10069; TRA0073406; CAS-95-56-7; NCGC00357156-01; 2-Bromophenol 100 microg/mL in Methanol; 2BR; 32762-51-9; AC-10760; BC002632; SC-07437; DB-024293; LS-104086; LS-104087; ST2409750; TC-062408; B0630; FT-0611593; ST50586121; AZ0001-0227; C14841; M-4711; 76489-EP2280011A1; 76489-EP2295424A1; 76489-EP2308960A1; A845333; Q26421079; InChI=1/C6H5BrO/c7-5-3-1-2-4-6(5)8/h1-4,8; o-Bromophenol; 4-06-00-01037 (Beilstein Handbook Reference)